Examining adherence barriers among women with HIV to tailor outreach for long-acting injectable antiretroviral therapy

Long-acting (LA) injectable antiretroviral therapy (ART) has been found non-inferior to daily oral ART in Phase 3 trials. LA ART may address key barriers to oral ART adherence and be preferable to daily pills ...

Source: BMC Women's Health - July 25, 2020 Category: OBGYN Authors: Lorie Benning, Andrea Mantsios, Deanna Kerrigan, Jenell S. Coleman, Elizabeth Golub, Oni Blackstock, Deborah Konkle-Parker, Morgan Philbin, Anandi Sheth, Adaora A. Adimora, Mardge H. Cohen, Dominika Seidman, Joel Milam, Seble G. Kassaye, Tonya Taylor and Tags: Research article Source Type: research